SecBot SecBot

CHUC

Charlie's Holdings, Inc.
OTC· Medicinal Chemicals & Botanical Products· Inc. NV· CIK 0001134765 Biotech & Drug Discovery
$0.1500 +0.01 (+7.14%)
Oct 26 4:00 PM ET · prev $0.1400
Next earnings
Nov 17
in 21 days
1 year
−40.0%
from $0.2501 · Oct 27
30 days
+1.2%
from $0.1482
52-week range
$0.0452–0.3214
−53% from high · low Oct 14
Avg volume 20D
79.2K
Oct 15 spike 524.1K
Short interest
🔒 Subscribers only
Insider net
+$270.0K
5 buyers · 0 sellers · 12 mo

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • B Feb 13 5 insiders buy $270.0K at $0.2000
  • X Jun 30 Short interest falls 45.0% to 19.7K
  • X Aug 31 Short interest jumps 168.5% to 50.3K
  • X Sep 15 Short interest falls 42.5% to 28.9K

Signal stack

Where each data set points today.

  • InsidersBULLISH

    5 insiders bought $270.0K at an average $0.2000. No open-market sales. Price is 25% below their cost.

  • TrendDOWNTREND

    10% below its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 3, 2026 Insider
King Michael D was granted 200,000 shares
Director
Sep 3, 2026 Insider
Stump Ryan was granted 200,000 shares
Chief Operating Officer
Sep 3, 2026 Insider
Montesano Matthew P was granted 500,000 shares
Chief Financial Officer
Aug 19, 2026 Earnings calendar
CHUC Q2 2026 Earnings Scheduled — 2026-08-19

Insider ledger

Form 4
$270.0K
bought · 5 insiders
$0
sold · 0 insiders
−25.0%
vs their $0.2000 cost
DateInsiderTypeValue
Sep 3, 2026
King Michael D
Director
AWARD200,000 sh
Sep 3, 2026
Stump Ryan
Chief Operating Officer
AWARD200,000 sh
Sep 3, 2026
Montesano Matthew P
Chief Financial Officer
AWARD500,000 sh
Sep 3, 2026
SICIGNANO HENRY III
President
AWARD500,000 sh
Sep 3, 2026
Fox Jeffrey G
Director
AWARD200,000 sh
Sep 3, 2026
Carmines Edward
Director
AWARD200,000 sh
Sep 3, 2026
Cohen Scot
Director
AWARD200,000 sh
Feb 13, 2026
Carmines Edward
Director
BUY$50.0K

Earnings setup

Estimates
Nov 17
reports in 21 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent